The NDI Guidance (NDIG) ranks as the No. 1 dietary supplement issue of 2011. Many see this guidance as a potential game changer. The NDIG comment period closed on December 2, and many still want to know:
*Who filed comments?
*What were the key points of agreement and disagreement?
*Will there be an authoritative ODI list?
*What becomes of probiotics?
*What will an NDI notice really cost?
*How do you know if you should really file an NDI notification?
*What are your risks if you don't?
*Is FDA actually enforcing this Guidance as if final?
Join Loren Israelsen, United Natural Products Alliance, and Dan Fabricant, Ph.D., Food & Drug Administration, to gain insights on these and other critical issues surrounding the NDI Guidance controversy. The webinar wil be held on Thursday, December 15, from 11 a.m. to 12:30 p.m. MT.